Alkermes
ALKS
#2182
Rank
โ‚ฌ7.95 B
Marketcap
47,75ย โ‚ฌ
Share price
5.53%
Change (1 day)
92.44%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): โ‚ฌ0.20 Billion

According to Alkermes's latest financial reports the company's current earnings are โ‚ฌ1.56 Billion. In 2025 the company made an earning of โ‚ฌ0.26 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.20 B-24.28%
2025 โ‚ฌ0.26 B-34.87%
2024 โ‚ฌ0.40 B-17.97%
2023 โ‚ฌ0.49 B-468.52%
2022 -โ‚ฌ0.14 Billion449.24%
2021 -โ‚ฌ24.58 Million-68.04%
2020 -โ‚ฌ76.88 Million-52.1%
2019 -โ‚ฌ0.17 Billion64.49%
2018 -โ‚ฌ97.57 Million-15.04%
2017 -โ‚ฌ0.12 Billion-34.2%
2016 -โ‚ฌ0.18 Billion-5.34%
2015 -โ‚ฌ0.19 Billion35084.97%
2014 -โ‚ฌ0.53 Million
2012 โ‚ฌ6.49 M-117.81%
2011 -โ‚ฌ36.47 Million-12.69%
2010 -โ‚ฌ41.77 Million94.3%
2009 -โ‚ฌ21.5 Million-117.7%
2008 โ‚ฌ0.12 B622.63%
2007 โ‚ฌ16.8 M
2004 -โ‚ฌ66.46 Million-14.48%
2003 -โ‚ฌ77.72 Million11.88%
2002 -โ‚ฌ69.47 Million39.65%
2001 -โ‚ฌ49.75 Million5.73%
2000 -โ‚ฌ47.05 Million-28.91%
1999 -โ‚ฌ66.18 Million237.28%
1998 -โ‚ฌ19.62 Million100.05%
1997 -โ‚ฌ9.81 Million-37.93%
1996 -โ‚ฌ15.8 Million82.72%
1995 -โ‚ฌ8.65 Million-26.79%
1994 -โ‚ฌ11.81 Million-72.78%
1993 -โ‚ฌ43.4 Million208.07%
1992 -โ‚ฌ14.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.72 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.80 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.26 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.69 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ8.39 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.82 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-โ‚ฌ0.19 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.24 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.98 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel